Form 8-K - Current report:
SEC Accession No. 0001193125-25-028691
Filing Date
2025-02-18
Accepted
2025-02-18 16:52:36
Documents
19
Period of Report
2025-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d908068d8k.htm   iXBRL 8-K 37223
2 EX-1.1 d908068dex11.htm EX-1.1 195437
3 EX-4.1 d908068dex41.htm EX-4.1 73852
4 EX-5.1 d908068dex51.htm EX-5.1 15068
5 EX-99.1 d908068dex991.htm EX-99.1 10109
9 GRAPHIC g908068g0218114711739.jpg GRAPHIC 1649
10 GRAPHIC g908068img1.jpg GRAPHIC 5575
  Complete submission text file 0001193125-25-028691.txt   554241

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sldb-20250218.xsd EX-101.SCH 2853
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20250218_lab.xml EX-101.LAB 17994
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20250218_pre.xml EX-101.PRE 11263
21 EXTRACTED XBRL INSTANCE DOCUMENT d908068d8k_htm.xml XML 3643
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 25635867
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)